The Silent Sentinel's Breach: Middle Lobe Syndrome Caused by Endobronchial Rupture of Mediastinal Tuberculous Lymphadenitis
Abstract
Middle lobe syndrome (MLS) is characterized by recurrent or chronic collapse of the right middle lobe of the lung. While non-vascular inflammatory causes dominate, endobronchial rupture of mediastinal tuberculous lymphadenitis causing obstructive MLS is an under-recognized entity that presents significant diagnostic challenges. In this context, we report the case of a 24-year-old male immigrant with no past medical history who presented with cough and right-sided chest pain. Chest radiography revealed right middle lobe alveolar opacity. He received empirical levofloxacin without radiological follow-up. Four months later, he experienced symptom recurrence associated with weight loss, asthenia, and night sweats. Repeat chest radiography revealed persistent middle lobe consolidation with ipsilateral pleural effusion. Sputum smear for acid-fast bacilli and PCR for Mycobacterium tuberculosis were negative. Chest CT confirmed necrotic mediastinal lymph nodes with endobronchial rupture into the middle lobe bronchus and cavitated middle lobe consolidation. Flexible bronchoscopy demonstrated mucosal infiltration and pearly-white stenosis of the middle lobar bronchus. Endobronchial biopsies revealed necrotizing epithelioid and giant-cell granulomatous inflammation. The diagnosis of obstructive MLS secondary to endobronchial tuberculosis following lymph node rupture was established, and antituberculosis therapy was initiated. In conclusion, tuberculous lymphadenitis with…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.